3 Stocks To Watch In The Coming Week: Disney, CVS Health, Uber
Investing.com | Aug 04, 2019 10:02
With the U.S.-China trade war escalating and no solution in sight, the mood in the market has suddenly turned bearish.
The last week was the worst for U.S. stocks in 2019 as investors rushed to reduce their risks after President Donald Trump threatened to slap more tariffs on Chinese imports from Sept. 1. The euphoria related to the Federal Reserve’s first rate cut in a decade also evaporated quickly after investors saw no assurances of further easing from the central bank.
These negative developments are putting investors in a tough spot as they weigh options in a market which has rebounded strongly from every correction. There are several important earnings announcements scheduled for the next week that are worth paying attention to. Here are our three picks:
h2 1. Disney/h2Riding on the success of its powerful content and future growth prospects, the Walt Disney Co. (NYSE:DIS) will report fiscal 2019 third-quarter earnings on Tuesday after the market. On average, analysts are expecting the company to post $1.72 a share profit on sales of $21.46 billion.
Disney’s stock has climbed almost 30% this year on the back of several recording-breaking film releases, the robust performance of its theme park business and hopes that its new streaming service, Disney+, will be a huge success.
Trading at $141.62 as of Friday's close, Disney shares hit a record high of $147.15 on July 29.
The mass media and entertainment conglomerate plans to introduce its Disney+ service later this year. Expectations are that it will pose a major challenge to Disney's main rival, Netflix (NASDAQ:NFLX).
With this upbeat environment for Disney stock, the possibility of escalating costs and the company's guidance for the rest of 2019 will be the two most important details to focus on.
h2 2. CVS Health/h2CVS Health (NYSE:CVS) will report second-quarter earnings on Wednesday before the market open. Analysts on average are expecting $1.69 a share profit on sales of $62.65 billion.
A healthy profit outlook for 2019 and a strong Q1 earnings report, however, have so far failed to boost investor confidence in the stock which is down 15% this year. It closed on Friday at $55.71 amid worries over the changing U.S. drug landscape and strong competition from Walgreens (NASDAQ:WBA).
Get The App
CVS in May boosted its adjusted earnings per share forecast for this year to $6.75-$6.90, higher than the $6.68- $6.88 that it had earlier forecast. Next week’s report will be important to see if the health giant is on track to deliver.
Concerns persist regarding the integration costs of its $69-billion merger with Aetna (NYSE:AET), which closed in late November, making the merged entity one of the largest health care insurance and benefits companies in the industry. The merger is a way for CVS to beef up its brick-and-mortar operations while boosting the services side of the business. It's a response to Amazon's (NASDAQ:AMZN) efforts at taking on the healthcare industry.
h2 3. Uber/h2Uber (NYSE:UBER) is another important name to keep an eye on as the world’s largest ride-hailing provider releases its second-quarter earnings on Thursday.
The company is likely to report a $2.1 a share loss on sales of $3.31 billion amid investors’ concern about eroding profitability on rising competition and costs.
Uber, which went public in May, will need to survive in a tough and competitive environment where consumers remain highly price conscious, HSBC analysts Masha Kahn and Henning Cosman wrote in a note last month. The main rival in North America, Lyft Inc. (NASDAQ:LYFT) often prices 20-25% below Uber in New York and Daimler AG-backed Bolt is now doing the same in London, they wrote.
Uber shares have remained in a bearish spell since the IPO in May. They closed down more than 2% on Friday.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.